CD4 and fungal infectious disease: Impaired bronchoalveolar macrophages, reduced CD4+ and CD8+ T cells, endothelial damage, destruction of pneumocytes and thrombosis associated with COVID-19 predisposes to secondary bacterial and opportunistic fungal infections.